Gregory Orloff
Impact in
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
- Physiology top 5%
- Nitric Oxide and Endothelin Effects
Papers in
- Hematology 10
- Multiple Myeloma Research and Treatments 6
- Hematopoietic Stem Cell Transplantation 3
- Oncology 9
- Cancer Treatment and Pharmacology 4
- CAR-T cell therapy research 2
- Co-authors
- James M. CunninghamCheryl LyonsDavid PorterFelicia B. AxelrodLisa M. CoussensCarmela M. CastiglioneXandra O. BreakefieldAxel Ullrich
- Journals
- Blood (4 papers)Journal of Clinical Oncology (3 papers)Bone Marrow Transplantation (1 paper)Journal of Biological Chemistry (1 paper)Biochemical Pharmacology (1 paper)
- Partner nations
- United StatesTürkiyeJapan
In The Last Decade
Gregory Orloff
16 papers receiving 933 citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Biochemistry 204
- Physiology 541
- Endocrine and Autonomic Systems 72
- Hematology 113
- Immunology 175
Countries citing papers authored by Gregory Orloff
This map shows the geographic impact of Gregory Orloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Orloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Orloff more than expected).
Fields of papers citing papers by Gregory Orloff
This network shows the impact of papers produced by Gregory Orloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Orloff. The network helps show where Gregory Orloff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gregory Orloff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United States | 2022 | 9 |
| 3 | 2019 | 6 | |
| 4 | 2018 | 5 | |
| 5 | 2017 | 2 | |
| 6 | 2017 | 13 | |
| 7 | 2015 | 1 | |
| 8 | 2013 | 30 | |
| 9 | 2010 | 14 | |
| 10 | 2006 | 0 | |
| 11 | 2005 | 12 | |
| 12 | 2001 | 34 | |
| 13 | 1996 | 13 | |
| 14 | Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant. | 1994 | 23 |
| 15 | Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. Hit paper breakdown → | 1992 | 758 |
| 16 | Thrombosis of the renal artery of a small, solitary kidney: successful return of renal function after prolonged anuria. | 1988 | 3 |
| 17 | 1984 | 36 |
About Gregory Orloff
Gregory Orloff is a scholar working on Hematology, Oncology, Genetics, Pediatrics, Perinatology and Child Health and Statistics and Probability, having authored 17 papers that have together received 960 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Cancer Treatment and Pharmacology (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Nitric Oxide and Endothelin Effects (2 papers), CAR-T cell therapy research (2 papers), Protein Degradation and Inhibitors (2 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Cancer Mechanisms and Therapy (1 paper). The work is most often cited by research in Biochemistry (204 citations), Physiology (541 citations), Endocrine and Autonomic Systems (72 citations), Hematology (113 citations) and Immunology (175 citations). Gregory Orloff has collaborated with scholars based in United States, Türkiye and Japan. Frequent co-authors include James M. Cunningham, Cheryl Lyons, David Porter, Felicia B. Axelrod, Lisa M. Coussens, Carmela M. Castiglione, Xandra O. Breakefield, Axel Ullrich, Donald E. Tsai and Edward A. Stadtmauer. Their work appears in journals such as Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, Journal of Biological Chemistry and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.